Connect with us

Business Wire

Franny’s Farmacy Expands National Reach Through Its Hemp Franchise and Retail Success

Published

on


Franny’s Farmacy Unveils Next Evolution of Company With Restructuring, Rebranding, New Products and More Retail Locations

ASHEVILLE, N.C.–(BUSINESS WIRE)–Pioneering hemp CBD brand Franny’s Farmacy today announced a strategic restructuring as the company expands nationwide. Shareholders of separate brand entities Franny’s Manufacturing and Franny’s Distribution are now shareholders in a new single entity—Franny’s Operations—representing the entire organization. The new business structure will further business collaborations and partnerships, while positioning Franny’s Farmacy as one of the most trusted consumer cannabis brands in the market.

Led by cannabis industry veteran and CEO Franny Tacy, Franny’s Farmacy is evolving with a new brand image, new products and more franchises poised to enter emerging recreational markets and existing legal-market cannabis states. Tacy is the first female hemp farmer in North Carolina in over 75 years and is actively engaged in hemp research trials with North Carolina State University. In the past decade, she has expanded the company from its headquarters in North Carolina to comprise 11 dispensaries in six states with a robust eCommerce portfolio and nationwide wholesale accounts.

“Franny Tacy has been a multifaceted leader in the nascent industrial hemp industry since its inception,“ said Robert Hoban, Global Cannabis Industry Expert and Co-Chair of Clark Hill Cannabis Industry Group. “She leads the everchanging hemp marketplace with a focus on its successfully implemented core competencies—retail, franchising, product development and supply chain management. The corporate restructure provides its current and future investors, customers, and employees with a design aimed to maximize tax efficiencies and affords it the ability to strategically expand into related endeavors across the country, and around the globe.”

Franny’s formulates a multitude of eco-friendly products from hemp foods to full-spectrum cannabinoid products designed for daily health and wellness. The company has also applied for Delta-9 THC licenses that will allow it to expand into legal cannabis markets.

About Franny’s Farmacy

Established in 2012, Franny’s Farmacy is a North Carolina-based, vertically integrated cannabis company dedicated to empowering personal health and wellness. A hemp farmer herself, founder Franny Tacy seeks to further U.S. hemp development and cannabinoid research while expanding consumer access to tested, quality-assured CBD and other plant-based products. With 11 dispensaries in six states and partnerships in legal THC markets, Franny’s Farmacy continues to grow its reach and influence. Learn more at frannysfarmacy.com.

Contacts

Franny’s Farmacy—Media

marketing@frannysfarmacy.com
828.216.2836

This post was originally published on this site



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business Wire

Switzerland Cannabis Markets Report 2023: Comprehensive Guide to the Size and Shape of this Emerging Market – Forecasts to 2027 – ResearchAndMarkets.com

Published

on

By


DUBLIN–(BUSINESS WIRE)–The “Cannabis in Switzerland” report has been added to ResearchAndMarkets.com’s offering.

The Cannabis in Switzerland market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth.

Following the current liberalisation of medical cannabis, the trend towards liberalisation of adult-use cannabis is also expected over the forecast period.

The consumption of products bought on the black market carries the risk of containing dangerous harmful substances or synthetic cannabinoids. For this reason, Swiss authorities will likely seek a compromise between prohibition and absolute legalisation of cannabis.

It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2027 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD, Medical Cannabis.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Cannabis market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Key Topics Covered:

CANNABIS IN SWITZERLAND

EXECUTIVE SUMMARY

CANNABIS BACKGROUND

COUNTRY INSIGHT

CANNABIS LEGISLATION

CANNABIS DISTRIBUTION

CANNABIS TAXATION

CANNABIS PRODUCTION

ILLICIT CANNABIS MARKET

MARKET INDICATORS

  • Cannabis User Population by Legal vs Illicit 2019-2022

MARKET DATA

  • Sales of Cannabis by Category: Value 2019-2022
  • Sales of Cannabis by Category: % Value Growth 2019-2022
  • Sales of Cannabis by Legal vs Illicit 2019-2022
  • Distribution of Cannabis by Format: % Value 2019-2022
  • Distribution of Cannabis by Format and Category: % Value 2022
  • Forecast Sales of Cannabis by Category: Value 2022-2027
  • Forecast Sales of Cannabis by Category: % Value Growth 2022-2027
  • Forecast Sales of Cannabis by Legal vs Illicit 2022-2027

MEDICAL CANNABIS

  • Market Sizes
  • Cannabinoids
  • Brands
  • Distribution

CATEGORY DATA

  • Sales of Medical Cannabis by Category: Volume 2019-2022
  • Sales of Medical Cannabis by Category: Value 2019-2022
  • Sales of Medical Cannabis by Category: % Volume Growth 2019-2022
  • Sales of Medical Cannabis by Category: % Value Growth 2019-2022
  • Sales of Medical Cannabis by CBD vs THC content: % Value 2019-2022
  • Distribution of Medical Cannabis by Format: % Value 2019-2022
  • Forecast Sales of Medical Cannabis by Category: Volume 2022-2027
  • Forecast Sales of Medical Cannabis by Category: Value 2022-2027
  • Forecast Sales of Medical Cannabis by Category: % Volume Growth 2022-2027
  • Forecast Sales of Medical Cannabis by Category: % Value Growth 2022-2027

ADULT-USE CANNABIS

  • Forecast Sales of Adult-Use Cannabis by Category: Volume 2022-2027
  • Forecast Sales of Adult-Use Cannabis by Category: Value 2022-2027
  • Forecast Sales of Adult-Use Cannabis by Category: % Volume Growth 2022-2027
  • Forecast Sales of Adult-Use Cannabis by Category: % Value Growth 2022-2027

CBD

  • Sales of CBD by Category: Volume 2019-2022
  • Sales of CBD by Category: Value 2019-2022
  • Sales of CBD by Category: % Volume Growth 2019-2022
  • Sales of CBD by Category: % Value Growth 2019-2022
  • Distribution of CBD by Format: % Value 2019-2022
  • Forecast Sales of CBD by Category: Volume 2022-2027
  • Forecast Sales of CBD by Category: Value 2022-2027
  • Forecast Sales of CBD by Category: % Volume Growth 2022-2027
  • Forecast Sales of CBD by Category: % Value Growth 2022-2027

For more information about this report visit https://www.researchandmarkets.com/r/ezqqm-in?w=4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

This post was originally published on this site



Source link

Continue Reading

Business Wire

Cresco Labs Welcomes Patients to 22nd Sunnyside Dispensary in Florida

Published

on

By


CHICAGO–(BUSINESS WIRE)–Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company), a vertically integrated multistate cannabis operator and the No. 1 U.S. wholesaler of branded products, today announced the opening of a new Sunnyside dispensary in Lutz, Florida. Sunnyside Lutz joins its sister locations in Tampa, Clearwater and St. Petersburgh in serving patients residing around the Tampa Bay area. The new store is Cresco Labs’ 22nd dispensary in Florida and 56th dispensary nationwide.

“We are pleased to expand the reach of Sunnyside and Cresco Labs’ leading portfolio of products to another group of patients residing in the Tampa region,” said Charles Bachtell, Cresco Labs’ CEO & Co-Founder. “We have plans to continue expansion in 2023, and we are excited to continue winning over more patients through a combination of excellent service, approachable prices and top-quality products.”

Sunnyside Lutz is located at 21708 FL-54 on State Road 54, an east/west throughfare and convenient access point for customers. The store offers a variety of cannabis products from Cresco Labs’ branded portfolio that includes Cresco, One Plant, Supply, Good News, Remedi and Sunnyside. The store also has a curated selection of accessories.

Patients can place orders today in store and online through the Sunnyside.shop website. Sunnyside Lutz store hours are Monday through Saturday, 9 AM to 8 PM, and Sunday, 9 AM to 6 PM.

About Cresco Labs

Cresco Labs, one of the largest multistate cannabis operators, strives to normalize and professionalize the cannabis industry through best-in-class cultivation, manufacturing, branded products, retail and initiatives that support and uplift the communities it serves. The largest wholesaler of branded products in 2021 and 2022, the company develops and distributes a robust portfolio of brands created to meet different customer needs, including FloraCal Farms, Cresco, High Supply, Mindy’s, Good News, Remedi and Wonder Wellness. Cresco Labs has operations in 10 states, with stores operating under its top-performing national retail brand, Sunnyside, in seven markets. Headquartered in Chicago, Cresco Labs launched in 2019 the cannabis industry’s first social equity initiative, SEEDTM (Social Equity and Educational Development), to address the absence of people, businesses and communities disproportionately impacted by the War on Drugs in cannabis. The company was recognized on Crain’s Chicago Business’ Fast 50 list in 2022 and Inc.’s Best Led Companies list in 2022. Learn more about Cresco Labs at www.crescolabs.com.

Facebook: Cresco Labs

Twitter: Cresco Labs

LinkedIn: Cresco Labs

Contacts

Media:
Jason Erkes, Cresco Labs

Chief Communications Officer

press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs

Senior Vice President, Investor Relations

investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993

info@crescolabs.com

This post was originally published on this site





Source link

Continue Reading

Business Wire

Nabis Commitment to Reinvestment Expands Resources and Teams Across Company, Strengthens California Presence

Published

on

By


Tech-Driven Cannabis Startup Promotes 20% of Workforce, Increases Annual Benefits and Headcount To Foster Company Health and Support Growing Ecosystem

SAN FRANCISCO–(BUSINESS WIRE)–Nabis, the leading licensed cannabis wholesale platform in the world’s largest legal cannabis market, reflects on a year of internal reinvestments that have advanced the company’s position as the industry’s one-stop-shop solution for operators in 2023. With its growing footprint now accounting for approximately 20% of California’s legal market, Nabis’ focus on recruiting top talent across eclectic industries to support its network of partners comes at a critical time in the cannabis and tech industries.

“It’s important that our employees feel valued, stay ahead of the broader financial complexities our society is experiencing, and are aligned with a clear vision and sense of purpose,” said Vince C. Ning, Co-Founder and Co-CEO of Nabis. “Over the last year, Nabis made it a point to implement a series of strategic internal reinvestments across product development, fulfillment, finance and policy teams, resulting in a boost to employee engagement and company culture. This, combined with our team expansion efforts, has given us the foundation to continue to advance the quality of service we give to our customers in order to create a more stable supply chain in the largest cannabis market in the world.”

To meet the industry’s growing demand for leveraging third-party distribution and fulfillment, Nabis grew its Operations division by 20% over the last year, and both the Finance and Partner Success teams by 40%. Notable company milestones over the past year also include:

  • 160+ new hires
  • 5 C-suite additions
  • 50+ internal promotions (20% of all Nabis employees)
  • 2.4% annual benefit increases
  • 88% favorable employee sentiment score

“Attracting and retaining talent emerged as a principal challenge for companies nationwide during 2022, especially those in the cannabis industry,” said Jake Borenstein, Head of People at Nabis. “Thanks to incentive-aligning employment packages, deep commitments to employee diversity, and a well-established culture of enthusiasm and career development, we have continued to reinforce and enhance the depth and drive of our team.”

With a core goal of creating an inclusive and equal-opportunity cannabis market, Nabis aims to build a diverse and dedicated talent pool that is equipped to support its robust ecosystem of partners. While applicants do need to be over the age of 21 and able to pass a background check, the company is dedicated to credential agnosticism—an approach that values experience and work ethic over education and credentials.

“We hire sensational talent from all backgrounds, and we never depend entirely on educational pedigrees,” said Borenstein. “We are striving to find the people that are passionate about the industry and share the same vision to help democratize it.”

Looking ahead, Nabis anticipates continued reinvestment in the pillars that support its dynamic vigor. In addition to focusing on credit management and scaling its distribution network, the company plans to continuously roll out new software product features to improve and automate internal and external processes for brands and retailers, such as the new BillPay portal.

For more information on career opportunities at Nabis, please visit nabis.com/careers.

About Nabis

Nabis is the #1 licensed cannabis wholesaling platform in California, supporting over 300 exclusive brands and supplying the entire network of state-licensed dispensaries with top-tier products. Nabis offers clients lightning-fast fulfillment, warehousing, payment processing, financing, data analytics, sales and marketing services to enable more brands and retailers to innovate, launch and scale. Founded in 2018 by serial tech entrepreneurs Vince C. Ning and Jun S. Lee, Nabis is fueled by cutting-edge technology designed to support cannabis wholesaling between brands and retailers. Nabis works directly with its partners to streamline the regulated cannabis wholesaling process by leveraging actionable, industry-leading sales data and insights to help brands and retailers scale strategically. Learn more: nabis.com

Contacts

Molly A. Sposato

Grasslands: A Journalism-Minded Agency

molly@mygrasslands.com
207-332-6121

This post was originally published on this site



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media